DOI QR코드

DOI QR Code

Acceptability of Human Papilloma Virus Vaccination among Women in the United Arab Emirates

  • Ortashi, Osman (Department of Obstetrics and Gynecology, College of Medicine and Health Sciences, United Arab Emirates University) ;
  • Raheel, Hina (Department of Obstetrics and Gynecology, College of Medicine and Health Sciences, United Arab Emirates University) ;
  • Shalal, Musa (Faculty of Humanities and Social Sciences, United Arab Emirates University)
  • Published : 2014.03.01

Abstract

Background: Human papilloma virus (HPV) is a common sexually transmitted infectious agent. It is estimated that 10% of all women worldwide are infected with HPV, that is some 660 million each year. HPV vaccination has a reported efficacy of more than 98% for protection against infection in females. In 2008 the Abu Dhabi Health Authority in the United Arab Emirates (UAE) introduced free HPV vaccination for all eligible schoolgirls in both public and private schools. Methods: A cross-sectional study of 640 women aged 18-50 years in the Emirate of Abu Dhabi in UAE from April 2012 to October 2012 was conducted. Results: Thirty-seven percent of the women in our sample had heard about HPV vaccination, and 80% of these would consider getting vaccinated themselves, and 87% would recommend vaccination to relatives or friends. Most women in the study (69%) had a favorable opinion about the vaccine. Only 17% of the women felt it might not be culturally acceptable, and 1% felt that there might be religious objections to HPV vaccination. Vaccine safety and recommendation by a doctor (36% each) were the factors identified most frequently by our sample of women which would enhance the uptake of the HPV vaccination. Conclusions: Knowledge about HPV vaccination among women in our sample was below average (37%); however, 80% of those who had heard about HPV vaccination were willing to be vaccinated themselves, and 87% would recommend vaccination to relatives and friends.

References

  1. Al Eyd G J, Shaik RB (2012). Rate of opportunistic pap smear screening and patterns of epithelial cell abnormalities in pap smears in Ajman, United Arab Emirates. Sultan Qaboos Univ Med J, 12, 473-478. https://doi.org/10.12816/0003173
  2. Al Sairafi M, Mohamed FA (2013). Knowledge, Attitudes, and Practice Related to Cervical Cancer Screening among Kuwaiti Women. Medical Principles and Practice, 18, 35-42.
  3. Al-Naggar RA, Bobryshev YV, Al-Jashamy K, Al-Musli M (2012). Practice of HPV vaccine and associated factors among school girls in Melaka, Malaysia. Asian Pac J Cancer Prev, 13, 3835-40. https://doi.org/10.7314/APJCP.2012.13.8.3835
  4. Bair RM, Mays RM, Sturm LA and Zimet GD (2008). Acceptability of the human papillomavirus vaccine among Latina mothers. J Pediatr Adolesc Gynecol, 21, 329-34. https://doi.org/10.1016/j.jpag.2008.02.007
  5. Chang L, Ci P, Shi J, et al (2013). Distribution of genital wart human papillomavirus genotypes in China: A multi-center study. J Med Virol, 85, 1765-74. https://doi.org/10.1002/jmv.23646
  6. D'Souza, G, Kreimer AR, Viscidi R, et al (2007). Case-control study of human papillomavirus and oropharyngeal cancer. N Engl J Med, 356, 1944-56. https://doi.org/10.1056/NEJMoa065497
  7. Durusoy, R., Yamazhan M, Tasbakan MI, et al (2010). HPV vaccine awareness and willingness of first-year students entering university in Western Turkey. Asian Pac J Cancer Prev, 11, 1695-701.
  8. Genc RE, Sarican ES, Turgay AS, et al. (2013). Determination of knowledge of Turkish midwifery students about human papilloma virus infection and its vaccines. Asian Pac J Cancer Prev, 14, 6775-8. https://doi.org/10.7314/APJCP.2013.14.11.6775
  9. Ghojazadeh M, Azar ZF, Saleh P, Naghavi-Behzad M, Azar NG (2012). Knowledge and attitude of Iranian University students toward human papilloma virus. Asian Pac J Cancer Prev, 13, 6115-9. https://doi.org/10.7314/APJCP.2012.13.12.6115
  10. Haesebaert J, Lutringer-Magnin D, Kalecinski J, et al (2012). French women's knowledge of and attitudes towards cervical cancer prevention and the acceptability of HPV vaccination among those with 14-18 year old daughters: a quantitativequalitative study. BMC Public Health, 12, 1034. https://doi.org/10.1186/1471-2458-12-1034
  11. Hodge FS, Itty T, Cardoza B, Samuel-Nakamura C (2011). HPV vaccine readiness among American Indian college students. Ethn Dis, 21, 415-20.
  12. Hoots BE, Palefsky JM, Pimenta JM, Smith JS (2009). Human papillomavirus type distribution in anal cancer and anal intraepithelial lesions. Int J Cancer, 124, 2375-83. https://doi.org/10.1002/ijc.24215
  13. Kilic A, Seven M, Guvenc G, Akyuz A, Ciftci S (2012). Acceptance of human papillomavirus vaccine by adolescent girls and their parents in Turkey. Asian Pac J Cancer Prev 13, 4267-72. https://doi.org/10.7314/APJCP.2012.13.9.4267
  14. Makwe CC, Anorlu RI, Odeyemi KA (2012). Human papillomavirus (HPV) infection and vaccines: Knowledge, attitude and perception among female students at the University of Lagos, Lagos, Nigeria. J Epidemiol Glob Health, 2, 199-206. https://doi.org/10.1016/j.jegh.2012.11.001
  15. Molokwu J, Fernandez NP, Martin C (2013). HPV Awareness and Vaccine Acceptability in Hispanic Women Living Along the US-Mexico Border. J Immigr Minor Health.
  16. Newman PA, Logie CH, Doukas N and Asakura K (2013). HPV vaccine acceptability among men: a systematic review and meta-analysis. Sex Transm Infect. 89, 568-74. https://doi.org/10.1136/sextrans-2012-050980
  17. Ortashi O, Shallal M, Osman N, Raheel H (2012) Knowledge, attitude and practice of school nurses in the United Arab Emirates about HPV infection and vaccine. Asian Pac J Cancer Prev, 13, 6481-4. https://doi.org/10.7314/APJCP.2012.13.12.6481
  18. Phan DP, Pham QT, Strobel M, et al (2012). [Acceptability of vaccination against human papillomavirus (HPV) by pediatricians, mothers and young women in Ho Chi Minh City, Vietnam]. Rev Epidemiol Sante Publique, 60, 437-46. https://doi.org/10.1016/j.respe.2012.03.010
  19. Sanchez Anguiano LF, Lechuga Quinones AM, Milla Villeda RH, Lares Bayona EF (2013). [Knowledge and acceptance of vaccine against human papillomavirus among mothers of students from Durango city, Mexico]. Ginecol Obstet Mex, 81, 77-85.
  20. Schiller JT, X Castellsague, SM Garland (2012). A review of clinical trials of human papillomavirus prophylactic vaccines. Vaccine, 30, 123-38. https://doi.org/10.1016/j.vaccine.2012.04.108
  21. Shekhar S, Sharma C, Thakur S, Raina N. (2013). Cervical cancer screening: knowledge, attitude and practices among nursing staff in a tertiary level teaching institution of rural India. Asian Pac J Cancer Prev, 14, 3641-5. https://doi.org/10.7314/APJCP.2013.14.6.3641
  22. Smith JS, Backes DM, Hoots BE, Kurman RJ, Pimenta JM (2009). Human papillomavirus type-distribution in vulvar and vaginal cancers and their associated precursors. Obstet Gynecol, 113, 917-24. https://doi.org/10.1097/AOG.0b013e31819bd6e0

Cited by

  1. Awareness of Risk Factors for Cancer among Omani adults- A Community Based Study vol.15, pp.13, 2014, https://doi.org/10.7314/APJCP.2014.15.13.5401
  2. Knowledge, Acceptance, and Willingness to Pay for Human Papilloma Virus (HPV) Vaccination among Female Parents in Thailand vol.15, pp.13, 2014, https://doi.org/10.7314/APJCP.2014.15.13.5469
  3. Knowledge on HPV Vaccine and Cervical Cancer Facilitates Vaccine Acceptability among School Teachers in Kitui County, Kenya vol.10, pp.8, 2015, https://doi.org/10.1371/journal.pone.0135563
  4. Innovations in HPV Vaccination and Roles of Nurses in Cervical Cancer Prevention vol.15, pp.23, 2015, https://doi.org/10.7314/APJCP.2014.15.23.10053